Cargando…
Control of Wnt Receptor Turnover by R-spondin-ZNRF3/RNF43 Signaling Module and Its Dysregulation in Cancer
Aberrant activation of the Wnt/β-catenin pathway is frequently found in various cancers, often through mutations of downstream components. Inhibiting β-catenin signaling in tumors with downstream pathway mutations remains challenging, due to a lack of favorable targets. On the other hand, targeting...
Autores principales: | Hao, Huai-Xiang, Jiang, Xiaomo, Cong, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931619/ https://www.ncbi.nlm.nih.gov/pubmed/27338477 http://dx.doi.org/10.3390/cancers8060054 |
Ejemplares similares
-
Structural and molecular basis of ZNRF3/RNF43 transmembrane ubiquitin ligase inhibition by the Wnt agonist R-spondin
por: Zebisch, Matthias, et al.
Publicado: (2013) -
USP42 protects ZNRF3/RNF43 from R‐spondin‐dependent clearance and inhibits Wnt signalling
por: Giebel, Nicole, et al.
Publicado: (2021) -
Ub and Dub of RNF43/ZNRF3 in the WNT signalling pathway
por: Colozza, Gabriele, et al.
Publicado: (2021) -
The R-spondin/Lgr5/Rnf43 module: regulator of Wnt signal strength
por: de Lau, Wim, et al.
Publicado: (2014) -
RNF43 and ZNRF3 in Wnt Signaling - A Master Regulator at the Membrane
por: Farnhammer, Fiona, et al.
Publicado: (2023)